Vestas CEO: US market likely to drop 80 pct in 2013

COPENHAGEN, June 10 Mon Jun 11, 2012 12:32am IST

Related Topics

Stocks

   

COPENHAGEN, June 10 (Reuters) - The head of the world's biggest wind turbine maker, Vestas, said on Sunday that the U.S. wind turbine market is likely to fall by 80 percent next year because of the expected expiry of an important tax credit.

The U.S. production tax credit (PTC) for renewable energy investment is due to expire at the end of this year, and, in an election year, it is widely believed that Congress will not pass legislation to renew it before the expiry.

"In the United States, the market this year is very, very busy," Vestas Chief Executive Ditlev Engel told a gathering of EU European affairs ministers and other senior officials at Vestas' research and development centre.

"But because of the potential lapse of the regulatory framework in the U.S., this market will probably go down 80 percent next year," he said.

That view of the potential for a steep drop was in line with analysts' estimates cited earlier by Vestas, including in material provided to shareholders before the annual general meeting in March.

But Engel's remarks made it clearer than ever that the company now also sees that as the likely scenario.

FILED UNDER:

"India's Daughter"

Reuters Showcase

Microfinance

Microfinance

Funding the unfunded: India helps small business borrow to grow  Full Article 

Insurance Sector

Insurance Sector

UK healthcare firm Bupa sees strong growth in India  Full Article 

Sensex Rises

Sensex Rises

Sensex edges up; consumer and healthcare stocks rise  Full Article 

Market Eye

Market Eye

FTSE adds nine Indian firms as large-caps in Asia-Pacific ex-Japan index   Full Article 

Indian Ocean Diplomacy

Indian Ocean Diplomacy

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

ECB Bond-Buying

ECB Bond-Buying

ECB raises growth forecasts, to start printing money next week  Full Article 

China Economy

China Economy

China signals "new normal" with lower annual growth target  Full Article 

Pharma Sector

Pharma Sector

Panel recommends waiving late-stage trials for some drugs  Full Article 

E-commerce

E-commerce

China backs e-commerce expansion in win for Alibaba, JD.com  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage